ERS statement on exercise training and rehabilitation in patients with severe chronic pulmonary hypertension

RECOMMENDED

Pulmonary Hypertension

Risk assessment in medically treated chronic thromboembolic pulmonary hypertension patients

Eur Respir J.

Delcroix M, Staehler G, Gall , Grünig E, Held M, Halank M, Klose H, Vonk-Noordegraaf A, Rosenkranz S, Pepke-Zaba J, Opitz CF, Gibbs JSR, Lange TJ, Tsangaris I, Huscher D, Pittrow D, Olsson KM, Hoeper MM

doi: 10.1183/13993003.

Pulmonary Hypertension

The impact of patient choice on survival in chronic thromboembolic pulmonary hypertension

Eur Respir J.

Quadery SR, Swift AJ, Billings C, Thompson A, Elliot CA, Hurdman J, Charalampopoulos A, Sabroe I, Armstrong I, Hamilton N, Sephton P, Garrod S, Pepke-Zaba J, Jenkins DP, Screaton N, Rothman AM, Lawrie A, Cleveland T, Thomas S, Rajaram S, Hill C, Davies C, Johns CS, Wild JM, Condliffe R, Kiely DG

doi: 10.1183/13993003.

COMMENTED

Pulmonary Hypertension

Effect of domiciliary oxygen therapy on exercise capacity and quality of life in patients with pulmonary arterial or chronic thromboembolic pulmonary hypertension: a randomised, placebo-controlled trial

Eur Respir J.

Ulrich S, Saxer S, Hasler ED, Schwarz EI, Schneider SR, Furian M, Bader PR, Lichtblau M, Bloch KE

doi: 10.1183/13993003.002762019.

RECOMMENDED

Pulmonary Hypertension

Subcutaneous treprostinil for the treatment of severe non-operable chronic thromboembolic pulmonary hypertension (CTREPH): a double-blind, phase 3, randomised controlled trial

Lancet Respir Med.

Sadushi-Kolici R, Jansa P, Kopec G, Torbicki A, Skoro-Sajer N, Campean IA, Halank M, Simkova I, Karlocai K, Steringer-Mascherbauer R, Samarzija M, Salobir B, Klepetko W, Lindner J, Lang IM

doi: 10.1016/S2213-2600

RECOMMENDED

COPDSleep Apnea

Prevalence and Predictors of Obstructive Sleep Apnea in Patients with Chronic Obstructive Pulmonary Disease Undergoing Inpatient Pulmonary Rehabilitation

COPD.

Schreiber A, Cemmi F, Ambrosino N, Ceriana P, Lastoria C, Carlucci A

doi: 10.1080/15412555.

RECOMMENDED

Pulmonary Hypertension

Right ventricular size and function under riociguat in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension (the RIVER study)

Respir Res.

Marra AM, Halank M, Benjamin N, Bossone E, Cittadini A, Eichstaedt CA, Egenlauf B, Harutyunova S, Fischer C, Gall H, Ghofrani HA, Hoeper MM, Lange TJ, Olsson KM, Klose H, Grünig E

doi: 10.1186/s12931-018-0957-y.

COPDPulmonary Hypertension

Pulmonary Arterial Histological Lesions in COPD Patients with Severe Pulmonary Hypertension

Chest.

Bunel V, Guyard A, Dauriat G, Danel C, Montani D, Gauvain C, Thabut G, Humbert M, Castier Y, Dorfmüller P, Mal H

doi: 10.1016/j.chest.

RECOMMENDED

Pulmonary Hypertension

Risk Assessment in Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension

Eur Respir J.

Humbert M, Farber HW, Ghofrani HA, Benza RL, Busse D, Meier C, Hoeper MM

doi: 10.1183/13993003.

COPD

The relationship between fear of movement, pain and fatigue severity, dyspnea level and comorbidities in patients with chronic obstructive pulmonary disease

Disabil Rehabil.

Vardar-Yagli N, Calik-Kutukcu E, Saglam M, Inal-Ince D, Arikan H, Coplu L

doi: 10.1080/09638288.

Related content

Risk assessment in medically treated chronic thromboembolic pulmonary hypertension patients

The impact of patient choice on survival in chronic thromboembolic pulmonary hypertension

Effect of domiciliary oxygen therapy on exercise capacity and quality of life in patients with pulmonary arterial or chronic thromboembolic pulmonary hypertension: a randomised, placebo-controlled trial

Subcutaneous treprostinil for the treatment of severe non-operable chronic thromboembolic pulmonary hypertension (CTREPH): a double-blind, phase 3, randomised controlled trial

Prevalence and Predictors of Obstructive Sleep Apnea in Patients with Chronic Obstructive Pulmonary Disease Undergoing Inpatient Pulmonary Rehabilitation

Right ventricular size and function under riociguat in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension (the RIVER study)

Pulmonary Arterial Histological Lesions in COPD Patients with Severe Pulmonary Hypertension

Risk Assessment in Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension

The relationship between fear of movement, pain and fatigue severity, dyspnea level and comorbidities in patients with chronic obstructive pulmonary disease